Article info
PDFResearch ethics
Paper
Deciphering assumptions about stepped wedge designs: the case of Ebola vaccine research
- Correspondence to Dr Adélaïde Doussau, Department of Bioethics, Clinical Center, National Institutes of Health, 10 Center Drive, Building 10/1C118, Bethesda, MD 20892-1156 USA; doussau2.adelaide{at}gmail.com
Citation
Deciphering assumptions about stepped wedge designs: the case of Ebola vaccine research
Publication history
- Received December 2, 2015
- Revised August 1, 2016
- Accepted September 19, 2016
- First published October 17, 2016.
Online issue publication
November 23, 2016
Article Versions
- Previous version (17 October 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/
Other content recommended for you
- Vaccine testing for emerging infections: the case for individual randomisation
- The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting
- Delaying and withholding interventions: ethics and the stepped wedge trial
- Cutting edge or blunt instrument: how to decide if a stepped wedge design is right for you
- Ebola: an opportunity for a clinical trial?
- The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola
- An epistemology of patient safety research: a framework for study design and interpretation. Part 2. Study design
- Effects of emergency obstetric care training on maternal and perinatal outcomes: a stepped wedge cluster randomised trial in South Africa
- Estimating the probability of demonstrating vaccine efficacy in the declining Ebola epidemic: a Bayesian modelling approach
- Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol